123 related articles for article (PubMed ID: 35513187)
21. Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
Sebag-Montefiore D; Meadows HM; Cunningham D; Plowman PN; Hurman DC; Davidson N; Grieve R; Levine E; Glynne-Jones R
Radiother Oncol; 2012 Aug; 104(2):155-60. PubMed ID: 22857859
[TBL] [Abstract][Full Text] [Related]
22. Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma.
Kumpitsch C; Moissl-Eichinger C; Pock J; Thurnher D; Wolf A
Sci Rep; 2020 Oct; 10(1):16582. PubMed ID: 33024215
[TBL] [Abstract][Full Text] [Related]
23. Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes.
Holliday EB; Lester SC; Harmsen WS; Eng C; Haddock MG; Krishnan S; Das P; Hallemeier CL
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):102-108. PubMed ID: 29907489
[TBL] [Abstract][Full Text] [Related]
24. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer.
Hayes RB; Ahn J; Fan X; Peters BA; Ma Y; Yang L; Agalliu I; Burk RD; Ganly I; Purdue MP; Freedman ND; Gapstur SM; Pei Z
JAMA Oncol; 2018 Mar; 4(3):358-365. PubMed ID: 29327043
[TBL] [Abstract][Full Text] [Related]
25. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
26. A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anus.
Ngan D; Chu J; Chander S; Michael M; Heriot AG; Ngan SY; Rischin D; Leong T
Asia Pac J Clin Oncol; 2019 Feb; 15(1):75-81. PubMed ID: 30536770
[TBL] [Abstract][Full Text] [Related]
27. Chemoradiotherapy for squamous cell carcinoma of the anal canal: Comparison of one versus two cycles mitomycin-C.
White EC; Goldman K; Aleshin A; Lien WW; Rao AR
Radiother Oncol; 2015 Nov; 117(2):240-5. PubMed ID: 26347494
[TBL] [Abstract][Full Text] [Related]
28. Changing patterns of anal canal carcinoma in the United States.
Nelson RA; Levine AM; Bernstein L; Smith DD; Lai LL
J Clin Oncol; 2013 Apr; 31(12):1569-75. PubMed ID: 23509304
[TBL] [Abstract][Full Text] [Related]
29. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
30. Squamous Cancers of the Rectum Demonstrate Poorer Survival and Increased Need for Salvage Surgery Compared With Squamous Cancers of the Anus.
Kulaylat AS; Hollenbeak CS; Stewart DB
Dis Colon Rectum; 2017 Sep; 60(9):922-927. PubMed ID: 28796730
[TBL] [Abstract][Full Text] [Related]
31. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
[TBL] [Abstract][Full Text] [Related]
32. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
33. Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy.
De B; Corrigan KL; Rooney MK; Ludmir EB; Das P; Smith GL; Taniguchi CM; Minsky BD; Koay EJ; Koong A; Morris VK; Messick CA; You YN; Chang GJ; Westney OL; Nogueras Gonzalez GM; Holliday EB
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):78-88. PubMed ID: 35589011
[TBL] [Abstract][Full Text] [Related]
34. Patterns of care for anal cancer in the United States - a comparison between academic and community cancer centers.
Pricolo VE; Bonvini M; Abelli CF
BMC Cancer; 2018 May; 18(1):567. PubMed ID: 29769057
[TBL] [Abstract][Full Text] [Related]
35. Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinoma.
Rogers JE; Jácome AAA; Ohinata A; Wolff R; Morris VK; Johnson B; Mehdizadeh A; Rothschild ND; Ahmed SU; Guerra JL; Eng C
Expert Rev Anticancer Ther; 2020 Oct; 20(10):901-908. PubMed ID: 32799569
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Squamous Cell Carcinoma Anal Canal treated with IMRT-VMAT-based Concurrent Chemoradiation: a Single Institutional Experience.
Singh K; Sathyamurthy A; Ramireddy JK; Ram TS
J Gastrointest Cancer; 2022 Mar; 53(1):161-169. PubMed ID: 33400211
[TBL] [Abstract][Full Text] [Related]
37. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
38. The influence of nasal bacterial microbiome diversity on the pathogenesis and prognosis of chronic rhinosinusitis patients with polyps.
Gan W; Zhang H; Yang F; Liu S; Liu F; Meng J
Eur Arch Otorhinolaryngol; 2021 Apr; 278(4):1075-1088. PubMed ID: 32960349
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.
Koerber SA; Slynko A; Haefner MF; Krug D; Schoneweg C; Kessel K; Kopp-Schneider A; Herfarth K; Debus J; Sterzing F
Radiat Oncol; 2014 May; 9():113. PubMed ID: 24886574
[TBL] [Abstract][Full Text] [Related]
40. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer.
Hernandez S; Das P; Holliday EB; Shen L; Lu W; Johnson B; Messick CA; Taniguchi CM; Skibber J; Ludmir EB; You YN; Smith GL; Bednarski B; Kostousov L; Koay EJ; Minsky BD; Tillman M; Portier S; Eng C; Koong AC; Chang GJ; Foo WC; Wang J; Soto LS; Morris VK
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
